Pituitary gland tumors represent approximately 10–15% of all brain tumors and the most
common neoplasms of the sellar region. Among them, pituitary adenomas are the …

No comprehensive classification system that guides prognosis and therapy of pituitary
adenomas exists. The 2022 WHO histopathology-based classification system can only be …

The pituitary gland is the body's master gland of the endocrine glands. Although it is a small
organ, many types of tumors can develop within it. The recently revised fifth edition of the …

Even without direct involvement, it has been difficult to avoid the debate in recent years
around “what to call pituitary neoplasms.” Across our community, the topic remains highly …

We read with interest “A tale of pituitary adenomas: to NET or not to NET” published in
Pituitary [1]. The members of the International Pituitary Pathology Club (IPPC) who proposed …

Abstract In 1932, Harvey Cushing first proposed pituitary adenoma (PA) as the term for the
cause of acromegaly. After nearly 90 years of research, PA is recognized as the second …

In this special issue, eminent international experts and collaborators from several continents
appraise the present landscape regarding aggressive pituitary tumors, from epidemiology …

Pituitary tumors are very complex and heterogeneous and have a very wide range of
proliferative and aggressive behaviors, and how to define and classify these tumors remains …

The fourth edition of the World Health Organization classification of endocrine tumors (EN-
WHO2017) was released in 2017. In this new edition, changes in the classification of non …

The classification of adenohypophysial neoplasms as “pituitary neuroendocrine
tumors”(PitNETs) was proposed in 2017 to reflect their characteristics as epithelial …